Competition concerns weighed on Redcare Pharmacy shares on Friday after their attempt to stabilize the previous day.
They were heading downwards towards the three-year low. Most recently, the stocks of the online pharmacy via XETRA lost 3.74 percent to 57.85 euros. The lowest level so far since January 2023 was 55.80 euros on Wednesday. The titles of its direct competitor DocMorris were also under pressure on Friday in Zurich at 7.1 percent.
Concerns about new competition continue after drugstore chain DM enters the market. On Friday it is now having an impact that DM competitor Rossmann has now confirmed that it is setting up its own online pharmacy. This had already cost both stocks their first recovery gains in late Thursday trading.
“We are working on it so intensively that I can tell you: the online pharmacy is coming,” announced management spokesman Raoul Roßmann. The pharmacy offering should therefore be controlled from the Netherlands – the country in which Redcare Pharmacy is also headquartered. Rossmann initially did not comment further on Thursday about the timing, scope and specific design of the online pharmacy.
/tih/mis
FRANKFURT (dpa-AFX)
Selected leverage products on DocMorris
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on DocMorris
The leverage must be between 2 and 20
Advertising
